Technology Prognosis

tracking technologies before you have to make a decision

Lofexidine (Proposed Name: Lucemyra)

April 9, 2018

Lofexidine is an oral alpha-2 adrenergic agonist proposed to mitigate symptoms of opioid withdrawal and to facilitate completion of opioid discontinuation treatment. If approved by the FDA, lofexidine would be the first non-opiod drug indicated to alleviate symptoms of opioid withdrawal.